Ukoniq indications withdrawn by the FDA; drug pipeline news in asthma, dermatology and oncology; and positive results announced for a novel postpartum depression treatment.

Topics:

Asthma/COPD Depression Leukemias/lymphomas/ And Other Hematologic Cancers Obstetrics and Gynecology Oncology Respiratory Diseases/Disorders